Fresenius SE & Co. KGaA (FSNUY)
OTCMKTS
· Delayed Price · Currency is USD
12.13
+0.03 (0.25%)
May 6, 2025, 3:58 PM EDT
Fresenius SE & Co. KGaA Revenue
In the year 2024, Fresenius SE & Co. KGaA had annual revenue of 21.83B EUR with 3.64% growth. Fresenius SE & Co. KGaA had revenue of 5.63B in the quarter ending December 31, 2024, with 4.72% growth.
Revenue
21.83B EUR
Revenue Growth
+3.64%
P/S Ratio
1.21
Revenue / Employee
123.71K EUR
Employees
176,486
Market Cap
27.24B USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 21.83B | 766.00M | 3.64% |
Dec 31, 2023 | 21.07B | -465.00M | -2.16% |
Dec 31, 2022 | 21.53B | -15.99B | -42.61% |
Dec 31, 2021 | 37.52B | 1.24B | 3.43% |
Dec 31, 2020 | 36.28B | 868.00M | 2.45% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.76B |
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Glass House Brands | 200.90M |
Elite Pharmaceuticals | 70.00M |
Northwest Biotherapeutics | 1.38M |
BioStem Technologies | 301.83M |
American Oncology Network | 1.76B |
Fresenius SE & Co. KGaA News
- 9 days ago - Fresenius: Holding On For Longer-Term Growth Driven By Demand In Kidney Care Segment - Seeking Alpha
- 4 weeks ago - Pacira Settles Patent Dispute Over Exparel With Fresenius, Delays Pain Med' Generics Entry Until 2030, Stock Jumps - Benzinga
- 4 weeks ago - Pacira surges on patent settlement with Fresenius - Seeking Alpha
- 5 weeks ago - Fresenius gets FDA approval for biosimilars of Amgen's bone-condition drugs - Seeking Alpha
- 7 weeks ago - Fresenius: Turnaround For Company, Stock Price - Seeking Alpha
- 2 months ago - Health Care Roundup: Market Talk - The Wall Street Journal
- 2 months ago - Fresenius SE & Co KGaA (FSNUF) Full Year 2024 Earnings Call Highlights: Strong Growth and ... - GuruFocus
- 2 months ago - Fresenius SE & Co. KGaA 2024 Q4 - Results - Earnings Call Presentation - Seeking Alpha